Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B

BACKGROUND AND OBJECTIVES: Hsa-miR-429 is increased in bladder cancer. Its roles in bladder cancer are poorly understood. METHODS: The expression levels of hsa-miR-429 and cyclin-dependent kinase inhibitor 2B (CDKN2B) were determined using Real-Time qPCR in a total of 50 patients with bladder cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Yang, Jiangeng, Liu, Yuchen, He, Anbang, Liu, Yuhan, Wu, Jianting, Liao, Xinhui, Lv, Zhaojie, Wang, Feng, Mei, Hongbing
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620291/
https://ncbi.nlm.nih.gov/pubmed/28978151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19878
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados